Works matching IS 13866346 AND DT 2023 AND VI 53 AND IP 5
Results: 10
Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease.
- Published in:
- Hepatology Research, 2023, v. 53, n. 5, p. 391, doi. 10.1111/hepr.13884
- By:
- Publication type:
- Article
Navitoclax improves acute‐on‐chronic liver failure by eliminating senescent cells in mice.
- Published in:
- Hepatology Research, 2023, v. 53, n. 5, p. 460, doi. 10.1111/hepr.13879
- By:
- Publication type:
- Article
Factors associated with liver injury and prognosis in advanced cancer patients treated with immune checkpoint inhibitors.
- Published in:
- Hepatology Research, 2023, v. 53, n. 5, p. 450, doi. 10.1111/hepr.13878
- By:
- Publication type:
- Article
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines).
- Published in:
- Hepatology Research, 2023, v. 53, n. 5, p. 383, doi. 10.1111/hepr.13892
- By:
- Publication type:
- Article
Quality of life in Dutch patients with primary biliary cholangitis: Discrepancies between patients' perspectives and objective disease parameters.
- Published in:
- Hepatology Research, 2023, v. 53, n. 5, p. 401, doi. 10.1111/hepr.13880
- By:
- Publication type:
- Article
The imbalance between NKG2A and NKG2D expression is involved in NK cell immunosuppression and tumor progression of patients with hepatitis B virus‐related hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2023, v. 53, n. 5, p. 417, doi. 10.1111/hepr.13877
- By:
- Publication type:
- Article
Significant association between HLA‐B*35:01 and onset of drug‐induced liver injury caused by Kampo medicines in Japanese patients.
- Published in:
- Hepatology Research, 2023, v. 53, n. 5, p. 440, doi. 10.1111/hepr.13874
- By:
- Publication type:
- Article
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study.
- Published in:
- Hepatology Research, 2023, v. 53, n. 5, p. 409, doi. 10.1111/hepr.13876
- By:
- Publication type:
- Article
Prognostic significance for recurrence of fibroblast growth factor receptor 2 in intrahepatic cholangiocarcinoma patients undergoing curative hepatic resection.
- Published in:
- Hepatology Research, 2023, v. 53, n. 5, p. 432, doi. 10.1111/hepr.13875
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Hepatology Research, 2023, v. 53, n. 5, p. 381, doi. 10.1111/hepr.13782
- Publication type:
- Article